Howe & Rusling’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.2M | Buy |
|
|||||
|
2025
Q1 | $4.42M | Buy |
|
|||||
|
2024
Q4 | $3.58M | Sell |
|
|||||
|
2024
Q3 | $4.23M | Buy |
|
|||||
|
2024
Q2 | $4.11M | Buy |
|
|||||
|
2024
Q1 | $3.4M | Buy |
|
|||||
|
2023
Q4 | $3.27M | Buy |
|
|||||
|
2023
Q3 | $2.69M | Sell |
|
|||||
|
2023
Q2 | $2.82M | Sell |
|
|||||
|
2023
Q1 | $2.63M | Sell |
|
|||||
|
2022
Q4 | $2.47M | Sell |
|
|||||
|
2022
Q3 | $2.51M | Buy |
|
|||||
|
2022
Q2 | $2.35M | Buy |
|
|||||
|
2022
Q1 | $2.17M | Sell |
|
|||||
|
2021
Q4 | $2.48M | Sell |
|
|||||
|
2021
Q3 | $2.22M | Sell |
|
|||||
|
2021
Q2 | $2.56M | Buy |
|
|||||
|
2021
Q1 | $7K | Sell |
|
|||||
|
2020
Q4 | $9K | Buy |
|
|||||
|
2020
Q3 | $8K | Hold |
|
|||||
|
2020
Q2 | $8K | Sell |
|
|||||
|
2020
Q1 | $9K | Hold |
|
|||||
|
2019
Q4 | $8K | Hold |
|
|||||
|
2019
Q3 | $6K | Hold |
|
|||||
|
2019
Q2 | $7K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $6K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $17K | Buy |
|
|||||
|
2017
Q4 | $7K | Hold |
|
|||||
|
2017
Q3 | $7K | Sell |
|
|||||
|
2017
Q2 | $8K | Sell |
|
|||||
|
2017
Q1 | $9K | Buy |
|
|||||
|
2016
Q4 | $6K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $1K | Hold |
|
|||||
|
2014
Q4 | $1K | Hold |
|
|||||
|
2014
Q3 | $1K | Hold |
|
|||||
|
2014
Q2 | $0 | Sell |
|
|||||
|
2014
Q1 | $18K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $19K | Hold |
|
|||||
|
2013
Q2 | $20K | Buy |
|